Azithromycin
Brand names: Zithromax
Azithromycin is a macrolide antibiotic used for a range of respiratory, skin and soft tissue, and sexually transmitted infections, valued for its long half-life and short treatment courses.
Adult dose
Paediatric dose
Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC; US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.
UK SPC, paediatric patients aged 6 months and older weighing <45 kg, single daily dose. Acute bacterial sinusitis / community-acquired pneumonia / acute bacterial skin and skin structure infections: 10 mg/kg/day for 3 days, or 10 mg/kg on day 1 then 5 mg/kg/day on days 2–5. Acute bacterial otitis media: single dose of 30 mg/kg, or 10 mg/kg/day for 3 days, or 10 mg/kg day 1 then 5 mg/kg/day days 2–5. Acute streptococcal tonsillitis and pharyngitis: 20 mg/kg/day for 3 days, or 12 mg/kg/day for 5 days.
Contraindications
- Hypersensitivity to azithromycin, erythromycin, any macrolide or ketolide antibiotic, or any excipient
- History of cholestatic jaundice/hepatic dysfunction associated with prior azithromycin use (US label)
Side effects
- Diarrhoea
- Nausea
- Vomiting
- Abdominal pain
- Headache
Interactions
- QT-prolonging drugs — increased risk of ventricular arrhythmia/torsades de pointes
- Warfarin/oral anticoagulants — may potentiate effect; monitor prothrombin time
- Nelfinavir — increased azithromycin concentrations; monitor for adverse reactions
Clinical monograph
How it works
It binds the bacterial 50S ribosomal subunit, inhibiting protein synthesis, and is bacteriostatic against susceptible organisms with notable activity against atypical pathogens.
Prescribing in practice
- It can prolong the QT interval, so use caution in those with existing QT prolongation, electrolyte disturbance, or taking other QT-prolonging drugs.
- Use cautiously in significant hepatic impairment and discontinue if signs of liver dysfunction develop.
- As a macrolide it interacts with several drugs and, like other antibiotics, carries a risk of Clostridioides difficile-associated diarrhoea.
Monitoring
Routine monitoring is not usually required for short courses; consider ECG and electrolytes where cardiac risk factors exist and monitor for hepatic or diarrhoeal adverse effects.
Counselling the patient
- Complete the full prescribed course even if you feel better.
- Report a fast or irregular heartbeat, fainting, or severe or persistent diarrhoea.
- Tell the prescriber about all your other medicines.
Evidence & guidelines
Azithromycin is well established for specific indications in UK practice; macrolide use is guided by local microbiology and resistance considerations.
Reference: NICE CG191 (Pneumonia); BASHH Chlamydia Guidelines; BTS CAP Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
- DRIP Score for Drug-Resistant Pneumonia · Pneumonia
- Sepsis Screening and Sepsis Six · UK Sepsis Trust; NICE NG51; Surviving Sepsis Campaign 2021
- Unintentional Weight Loss Workup · NICE NG12; BSG
- Chronic Fatigue Workup · NICE NG206; BMJ Best Practice
- Lymphadenopathy Workup · NICE NG12; BMJ Best Practice
- Pre-op Medical Clearance · NICE NG45; ESC 2022
- Secondary Hypertension Workup · NICE NG136; ESH 2023